{"disease":{"id":"cardiac-decompensation","name":"Cardiac Decompensation","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"chembl-chembl1200418","indication_name":"Inotropic support in cardiac decompensation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DOBUTAMINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"dobutamine-hydrochloride","indication_name":"Cardiac Decompensation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","generic_name":"Dobutamine Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Beta-receptors of the heart","drug_class":"Inotropic agent","quality_score":10,"revenue":null,"mechanism":"Direct-acting inotropic agent stimulating cardiac beta-receptors with mild chronotropic and vasodilative effects."},{"drug_id":"dobutamine-hydrochloride","indication_name":"Cardiac Decompensation Post Cardiac Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","generic_name":"Dobutamine Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Beta-receptors of the heart","drug_class":"Inotropic agent","quality_score":10,"revenue":null,"mechanism":"Direct-acting inotropic agent stimulating cardiac beta-receptors with mild chronotropic and vasodilative effects."},{"drug_id":"dobutamine","indication_name":"Cardiac Decompensation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","generic_name":"DOBUTAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta-Adrenergic Agonist","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"dobutamine","indication_name":"Cardiac Decompensation Post Cardiac Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container","generic_name":"DOBUTAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta-Adrenergic Agonist","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"dobutamin","indication_name":"Cardiac Decompensation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Dobutamin","company_name":"Competence Network for Congenital Heart Defects","drug_phase":"discontinued","molecular_target":"Solute carrier family 22 member 1, Alpha-1D adrenergic receptor, Alpha-2B adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"dobutamin","indication_name":"Cardiac Decompensation Post Cardiac Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Dobutamin","company_name":"Competence Network for Congenital Heart Defects","drug_phase":"discontinued","molecular_target":"Solute carrier family 22 member 1, Alpha-1D adrenergic receptor, Alpha-2B adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":7,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06628973","title":"Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT02769351","title":"Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration","phase":"","overall_status":"TERMINATED","enrollment_count":104,"lead_sponsor_name":"Fresenius Medical Care Deutschland GmbH","has_results":true},{"nct_id":"NCT03515980","title":"An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03730961","title":"An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true}],"total":4},"guidelines":[{"drug_id":"dobutamine-hydrochloride","guideline_body":"FDA label","recommendation":"Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from organic heart disease.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"dobutamine-hydrochloride","guideline_body":"FDA label","recommendation":"Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from cardiac surgical procedures.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"dobutamine-hydrochloride","guideline_body":"FDA label","recommendation":"Dobutamine Hydrochloride in 5% Dextrose Injection can be used for inotropic support in the short-term treatment of patients with cardiogenic shock.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"dobutamine-hydrochloride","guideline_body":"FDA label","recommendation":"Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with decompensated cardiac failure.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"dobutamine-hydrochloride","guideline_body":"FDA label","recommendation":"Dobutamine Hydrochloride in 5% Dextrose Injection is indicated for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from organic cardiac disease.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"dobutamine-hydrochloride","guideline_body":"FDA label","recommendation":"Dobutamine Hydrochloride in 5% Dextrose Injection can be used for stress echocardiography.","line_of_therapy":"any","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}